Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ

标题
Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ
作者
关键词
-
出版物
JOURNAL OF CLINICAL PATHOLOGY
Volume 65, Issue 12, Pages 1088-1096
出版商
BMJ
发表日期
2012-09-04
DOI
10.1136/jclinpath-2012-200940

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now